VBIO (Valion Bio, Inc. Common Stock) Stock Analysis - Politician Trades
Valion Bio, Inc. Common Stock (VBIO) is a publicly traded the market company. As of May 21, 2026, VBIO trades at $0.85 with a market cap of $2.70M and a P/E ratio of 0.00. VBIO moved +0.00% today. Year to date, VBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.80 to $1.21. Rallies surfaces VBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded VBIO stock?
Rallies tracks politician and congressional stock disclosures for VBIO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
LoConti Joseph E. bought 1.00K (~$200) on Jul 29, 2021.
LoConti Joseph E. bought 13.00K (~$2.60K) on Jul 20, 2021.
LoConti Joseph E. bought 40.00K (~$6.40K) on Jul 19, 2021.
VBIO Analyst Consensus
VBIO analyst coverage data. Average price target: $0.00.
Common questions about VBIO
Which politicians traded VBIO stock?
Rallies tracks politician and congressional stock disclosures for VBIO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in VBIO?
Yes. Rallies tracks politician and congressional stock disclosures for VBIO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is VBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VBIO. It does not provide personalized investment advice.
